179 related articles for article (PubMed ID: 26265061)
1. Investigating the role of Pluronic-g-Cationic polyelectrolyte as functional stabilizer for nanocrystals: Impact on Paclitaxel oral bioavailability and tumor growth.
Sharma S; Verma A; Pandey G; Mittapelly N; Mishra PR
Acta Biomater; 2015 Oct; 26():169-83. PubMed ID: 26265061
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles.
Mo R; Jin X; Li N; Ju C; Sun M; Zhang C; Ping Q
Biomaterials; 2011 Jul; 32(20):4609-20. PubMed ID: 21440934
[TBL] [Abstract][Full Text] [Related]
3. Development of stabilized Paclitaxel nanocrystals: In-vitro and in-vivo efficacy studies.
Sharma S; Verma A; Teja BV; Shukla P; Mishra PR
Eur J Pharm Sci; 2015 Mar; 69():51-60. PubMed ID: 25559064
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Surfactant on Paclitaxel Nanocrystals: An In Vitro and In Vivo Study.
Liu H; Ma Y; Liu D; Fallon JK; Liu F
J Biomed Nanotechnol; 2016 Jan; 12(1):147-53. PubMed ID: 27301180
[TBL] [Abstract][Full Text] [Related]
5. Trimethyl chitosan based conjugates for oral and intravenous delivery of paclitaxel.
He R; Yin C
Acta Biomater; 2017 Apr; 53():355-366. PubMed ID: 28189812
[TBL] [Abstract][Full Text] [Related]
6. Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: preparation, characterization and antitumor activity.
Patel K; Patil A; Mehta M; Gota V; Vavia P
Int J Pharm; 2014 Sep; 472(1-2):214-23. PubMed ID: 24954663
[TBL] [Abstract][Full Text] [Related]
7. Effects of PEGylated paclitaxel nanocrystals on breast cancer and its lung metastasis.
Zhang H; Hu H; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Nanoscale; 2015 Jun; 7(24):10790-800. PubMed ID: 26038337
[TBL] [Abstract][Full Text] [Related]
8. Self-assembled micelles based on N-octyl-N'-phthalyl-O-phosphoryl chitosan derivative as an effective oral carrier of paclitaxel.
Qu G; Hou S; Qu D; Tian C; Zhu J; Xue L; Ju C; Zhang C
Carbohydr Polym; 2019 Mar; 207():428-439. PubMed ID: 30600025
[TBL] [Abstract][Full Text] [Related]
9. Amphiphilic carboxymethyl chitosan-quercetin conjugate with P-gp inhibitory properties for oral delivery of paclitaxel.
Wang X; Chen Y; Dahmani FZ; Yin L; Zhou J; Yao J
Biomaterials; 2014 Aug; 35(26):7654-65. PubMed ID: 24927684
[TBL] [Abstract][Full Text] [Related]
10. Bile salt liposomes for enhanced lymphatic transport and oral bioavailability of paclitaxel.
Zhang B; Xue A; Zhang C; Yu J; Chen W; Sun D
Pharmazie; 2016 Jun; 71(6):320-6. PubMed ID: 27455550
[TBL] [Abstract][Full Text] [Related]
11. Multi-functional chitosan polymeric micelles as oral paclitaxel delivery systems for enhanced bioavailability and anti-tumor efficacy.
Chen T; Tu L; Wang G; Qi N; Wu W; Zhang W; Feng J
Int J Pharm; 2020 Mar; 578():119105. PubMed ID: 32018019
[TBL] [Abstract][Full Text] [Related]
12. N-Deoxycholic acid-N,O-hydroxyethyl Chitosan with a Sulfhydryl Modification To Enhance the Oral Absorptive Efficiency of Paclitaxel.
Yu Y; Huo M; Fu Y; Xu W; Cai H; Yao L; Chen Q; Mu Y; Zhou J; Yin T
Mol Pharm; 2017 Dec; 14(12):4539-4550. PubMed ID: 29058910
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of intestinal permeation enhancement with carboxymethyl chitosan-rhein polymeric micelles for oral delivery of paclitaxel.
Wang X; Qiu L; Wang X; Ouyang H; Li T; Han L; Zhang X; Xu W; Chu K
Int J Pharm; 2020 Jan; 573():118840. PubMed ID: 31715358
[TBL] [Abstract][Full Text] [Related]
14. A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel.
Hu H; Lin Z; He B; Dai W; Wang X; Wang J; Zhang X; Zhang H; Zhang Q
J Control Release; 2015 Dec; 220(Pt A):189-200. PubMed ID: 26474677
[TBL] [Abstract][Full Text] [Related]
15. Supramolecular micellar nanoaggregates based on a novel chitosan/vitamin E succinate copolymer for paclitaxel selective delivery.
Lian H; Sun J; Yu YP; Liu YH; Cao W; Wang YJ; Sun YH; Wang SL; He ZG
Int J Nanomedicine; 2011; 6():3323-34. PubMed ID: 22228999
[TBL] [Abstract][Full Text] [Related]
16. Formulation, Pharmacokinetic Evaluation and Cytotoxicity of an Enhanced- penetration Paclitaxel Nanosuspension.
Cao Y; Wei Z; Li M; Wang H; Yin L; Chen D; Wang Y; Chen Y; Yuan Q; Pu X; Zong L; Duan S
Curr Cancer Drug Targets; 2019; 19(4):338-347. PubMed ID: 29956630
[TBL] [Abstract][Full Text] [Related]
17. Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel.
Jain S; Kumar D; Swarnakar NK; Thanki K
Biomaterials; 2012 Oct; 33(28):6758-68. PubMed ID: 22748771
[TBL] [Abstract][Full Text] [Related]
18. Novel polymer coupled lipid nanoparticle of paclitaxel with synergistic enhanced efficacy against cancer.
Singodia D; Talegaonkar S; Khar RK; Mishra PR
J Biomed Nanotechnol; 2011 Feb; 7(1):125-6. PubMed ID: 21485835
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen-Bonded Tannic Acid-Based Anticancer Nanoparticle for Enhancement of Oral Chemotherapy.
Le Z; Chen Y; Han H; Tian H; Zhao P; Yang C; He Z; Liu L; Leong KW; Mao HQ; Liu Z; Chen Y
ACS Appl Mater Interfaces; 2018 Dec; 10(49):42186-42197. PubMed ID: 30444601
[TBL] [Abstract][Full Text] [Related]
20. Enhancement on oral absorption of paclitaxel by multifunctional pluronic micelles.
Li Y; Bi Y; Xi Y; Li L
J Drug Target; 2013 Feb; 21(2):188-99. PubMed ID: 23126604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
